155 related articles for article (PubMed ID: 35964271)
1. COVAD survey 2 long-term outcomes: unmet need and protocol.
Fazal ZZ; Sen P; Joshi M; Ravichandran N; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Selva-O'Callaghan A; Nune A; Knitza J; Kuwana M; Gutiérrez CT; Caballero-Uribe CV; Dey D; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatol Int; 2022 Dec; 42(12):2151-2158. PubMed ID: 35964271
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 vaccination in autoimmune disease (COVAD) survey protocol.
Sen P; Gupta L; Lilleker JB; Aggarwal V; Kardes S; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; O'Callaghan AS; Nikiphorou E; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Cagnotto G; Nune A; Distler O; Chinoy H; Aggarwal V; Aggarwal R;
Rheumatol Int; 2022 Jan; 42(1):23-29. PubMed ID: 34779868
[TBL] [Abstract][Full Text] [Related]
3. Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
Sen P; R N; Houshmand N; Moghadam Kia S; Joshi M; Saha S; Jagtap K; Agarwal V; Nune A; Nikiphorou E; Tan AL; Shinjo SK; Ziade N; Velikova T; Milchert M; Parodis I; Gracia-Ramos AE; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Akawatcharangura Goo P; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Vaidya B; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Distler O; Saavedra MA; Day J; Chinoy H; ; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Oct; 62(10):3291-3301. PubMed ID: 36734536
[TBL] [Abstract][Full Text] [Related]
4. Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period-a cross-sequential study based on COVAD surveys.
Jagtap K; Naveen R; Day J; Sen P; Vaidya B; Nune A; Nikiphorou E; Tan AL; Agarwal V; Saha S; Shinjo SK; Ziade N; Joshi M; Velikova T; Milchert M; Parodis I; Edgar Gracia-Ramos A; Cavagna L; Kuwana M; Knitza J; Makol A; Patel A; Pauling JD; Wincup C; Barman B; Zamora Tehozol EA; Rojas Serrano J; García-De La Torre I; Colunga-Pedraza IJ; Merayo-Chalico J; Chibuzo OC; Katchamart W; Goo PA; Shumnalieva R; Chen YM; Hoff LS; El Kibbi L; Halabi H; Sazliyana Shaharir S; Hasan ATMT; Dey D; Gutiérrez CET; Caballero-Uribe CV; Lilleker JB; Salim B; Gheita T; Chatterjee T; Saavedra MA; Distler O; ; Chinoy H; Agarwal V; Aggarwal R; Gupta L
Rheumatology (Oxford); 2023 Dec; 62(12):3838-3848. PubMed ID: 36961331
[TBL] [Abstract][Full Text] [Related]
5. Perceptions and Concerns Regarding COVID-19 Vaccination in a Military Base Population.
Theis SR; Li PC; Kelly D; Ocampo T; Berglund A; Morgan D; Markert R; Fisher E; Burtson K
Mil Med; 2022 Oct; 187(11-12):e1255-e1260. PubMed ID: 34117501
[TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
Sen P; Ravichandran N; Nune A; Lilleker JB; Agarwal V; Kardes S; Kim M; Day J; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Selva O'Callaghan A; Nikiphorou E; Chatterjee T; Tan AL; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Rheumatology (Oxford); 2022 Dec; 62(1):65-76. PubMed ID: 35713499
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
Gil-Vila A; Ravichandran N; Selva-O'Callaghan A; Sen P; Nune A; Gaur PS; Gonzalez RA; Lilleker JB; Joshi M; Agarwal V; Kardes S; Kim M; Day J; Makol A; Milchert M; Gheita T; Salim B; Velikova T; Gracia-Ramos AE; Parodis I; Nikiphorou E; Tan AL; Chatterjee T; Cavagna L; Saavedra MA; Shinjo SK; Ziade N; Knitza J; Kuwana M; Distler O; Chinoy H; Agarwal V; Aggarwal R; Gupta L;
Muscle Nerve; 2022 Oct; 66(4):426-437. PubMed ID: 35869701
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 vaccine research and immunization strategies for improved control of the COVID-19 pandemic.
Shao Y; Wu Y; Feng Y; Xu W; Xiong F; Zhang X
Front Med; 2022 Apr; 16(2):185-195. PubMed ID: 35226300
[TBL] [Abstract][Full Text] [Related]
10. Vaccine hesitancy in the era of COVID-19: could lessons from the past help in divining the future?
Wiysonge CS; Ndwandwe D; Ryan J; Jaca A; Batouré O; Anya BM; Cooper S
Hum Vaccin Immunother; 2022 Dec; 18(1):1-3. PubMed ID: 33684019
[TBL] [Abstract][Full Text] [Related]
11. Safety and immunogenicity following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373): a secondary analysis of a randomised, placebo-controlled, phase 2 trial.
Mallory RM; Formica N; Pfeiffer S; Wilkinson B; Marcheschi A; Albert G; McFall H; Robinson M; Plested JS; Zhu M; Cloney-Clark S; Zhou B; Chau G; Robertson A; Maciejewski S; Hammond HL; Baracco L; Logue J; Frieman MB; Smith G; Patel N; Glenn GM;
Lancet Infect Dis; 2022 Nov; 22(11):1565-1576. PubMed ID: 35963274
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine hesitancy in patients with systemic autoimmune rheumatic disease: an interview-based survey.
Gaur P; Agrawat H; Shukla A
Rheumatol Int; 2021 Sep; 41(9):1601-1605. PubMed ID: 34213580
[TBL] [Abstract][Full Text] [Related]
13. Delayed adverse events following COVID-19 vaccination in patients with systemic sclerosis and other autoimmune diseases: a substudy of the COVAD-2 cohort.
Panchawagh S; Bohdana D; Kuwana M; Yoshida A; Yomono K; Pauling JD; Makol A; Kadam E; Day J; Chatterjee T; Katchamart W; Goo PA; Nikiphorou E; Sen P; Dey D; Cavagna L; Gutiérrez CET; Agarwal V; Milchert M; Ziade N; Distler O; Group CS; Chinoy H; Aggarwal R; Gupta L; Agarwal V
Rheumatol Int; 2023 Dec; 43(12):2211-2220. PubMed ID: 37712977
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 vaccines: concerns beyond protective efficacy and safety.
Lai CC; Chen IT; Chao CM; Lee PI; Ko WC; Hsueh PR
Expert Rev Vaccines; 2021 Aug; 20(8):1013-1025. PubMed ID: 34180347
[TBL] [Abstract][Full Text] [Related]
15. Booster vaccination strategy: Necessity, immunization objectives, immunization strategy, and safety.
Meng H; Mao J; Ye Q
J Med Virol; 2022 Jun; 94(6):2369-2375. PubMed ID: 35028946
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 vaccination hesitancy among people with chronic neurological disorders: A position paper.
Rakusa M; Öztürk S; Moro E; Helbok R; Bassetti CL; Beghi E; Bereczki D; Bodini B; Di Liberto G; Jenkins TM; Macerollo A; Maia LF; Martinelli-Boneschi F; Pisani A; Priori A; Sauerbier A; Soffietti R; Taba P; von Oertzen TJ; Zedde M; Crean M; Burlica A; Cavallieri F; Sellner J;
Eur J Neurol; 2022 Aug; 29(8):2163-2172. PubMed ID: 35460319
[TBL] [Abstract][Full Text] [Related]
17. Using BCG vaccine to enhance non-specific protection of health care workers during the COVID-19 pandemic: A structured summary of a study protocol for a randomised controlled trial in Denmark.
Madsen AMR; Schaltz-Buchholzer F; Benfield T; Bjerregaard-Andersen M; Dalgaard LS; Dam C; Ditlev SB; Faizi G; Johansen IS; Kofoed PE; Kristensen GS; Loekkegaard ECL; Mogensen CB; Mohamed L; Ostenfeld A; Oedegaard ES; Soerensen MK; Wejse C; Jensen AKG; Nielsen S; Krause TG; Netea MG; Aaby P; Benn CS
Trials; 2020 Sep; 21(1):799. PubMed ID: 32943115
[TBL] [Abstract][Full Text] [Related]
18. Neurological Complications Following COVID-19 Vaccination.
Chatterjee A; Chakravarty A
Curr Neurol Neurosci Rep; 2023 Jan; 23(1):1-14. PubMed ID: 36445631
[TBL] [Abstract][Full Text] [Related]
19. Is there a role for childhood vaccination against COVID-19?
Eberhardt CS; Siegrist CA
Pediatr Allergy Immunol; 2021 Jan; 32(1):9-16. PubMed ID: 33113210
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]